Individualised dual antiplatelet therapy in a patient with short bowel syndrome after acute myocardial infarction with coronary artery stenting.

about

Individualised dual antiplatelet therapy in a patient with short bowel syndrome after acute myocardial infarction with coronary artery stenting.

Item

http://www.wikidata.org/entity/Q41343370

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Individualised dual antiplatel ...... with coronary artery stenting.

@en

type

Item

label

Individualised dual antiplatel ...... with coronary artery stenting.

@en

prefLabel

Individualised dual antiplatel ...... with coronary artery stenting.

@en

P1476

Individualised dual antiplatel ...... with coronary artery stenting.

@en

P2093

Athanasios Karathanos

http://www.w3.org/2001/XMLSchema#string

Meinrad Gawaz

http://www.w3.org/2001/XMLSchema#string

Michal Droppa

http://www.w3.org/2001/XMLSchema#string

Tobias Geisler

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding

Drug insight: Clopidogrel nonresponsiveness

Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood

Aspirin and clopidogrel resistance.

Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

Pharmacokinetic basis of the antiplatelet action of prasugrel.

Pharmacokinetic, pharmacodynamic and pharmacogenetic profile of the oral antiplatelet agent ticagrelor.

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Gro

P31

scholarly article

case report

P356

10.1136/BCR-2014-205227

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Michal Droppa

P577

2015-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280031313

http://www.w3.org/2001/XMLSchema#string

P698

26150610

http://www.w3.org/2001/XMLSchema#string

P932

4493205

http://www.w3.org/2001/XMLSchema#string